Herriot Tabuteau

2019

In 2019, Herriot Tabuteau earned a total compensation of $4.7M as Chief Executive Officer and Chairman of the Board at Axsome Therapeutics, a 346% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$326,250
Option Awards$3,954,503
Salary$435,000
Total$4,715,754

Tabuteau received $4M in option awards, accounting for 84% of the total pay in 2019.

Tabuteau also received $326.3K in non-equity incentive plan and $435K in salary.

Rankings

In 2019, Herriot Tabuteau's compensation ranked 2,389th out of 13,971 executives tracked by ExecPay. In other words, Tabuteau earned more than 82.9% of executives.

ClassificationRankingPercentile
All
2,389
out of 13,971
83rd
Division
Manufacturing
864
out of 5,695
85th
Major group
Chemicals And Allied Products
280
out of 2,194
87th
Industry group
Drugs
225
out of 1,880
88th
Industry
Pharmaceutical Preparations
165
out of 1,392
88th

Pay ratio

Herriot Tabuteau's Pay$4,715,754
Median Employee's Pay$166,021
Pay Ratio

28

to 1

In 2019, the annual total compensation of Herriot Tabuteau was $4,715,754.

The annual total compensation of the median employee at Axsome Therapeutics was $166,021.

The ratio of Herriot Tabuteau's pay to the pay of median employee was therefore 28 to one.

Source: SEC filing on April 21, 2020.

Tabuteau's colleagues

We found three more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2019.

2019

David Marek

Axsome Therapeutics

Chief Commercial Officer

2019

Mark MA

Axsome Therapeutics

Chief Operating Officer

2019

Nick Pizzie

Axsome Therapeutics

Chief Financial Officer

News

In-depth

You may also like